Page 104 - JSOM Winter 2024
P. 104

Updated Findings on the Efficacy of Combined Subanesthetic

                     Ketamine Infusion and Cervical Sympathetic Blockade as a
                                 Symptomatic Treatment of PTSD/TBI in a
                             Special Forces Patient with a 2-year Follow-up

                                                   A Case Report



                                                                    2
                                             1
                           Eugene Lipov, MD *; Zubin Sethi, OMS-IV ; Hunter Rolain, OMS-IV  3



          ABSTRACT
          Posttraumatic stress disorder (PTSD)/blast traumatic brain in-  seems to have a synergistic effect on the symptoms of bTBI and
          jury (bTBI) in a Special Operations Forces (SOF) cohort has   PTSD in the SOF cohort.
          been shown to be successfully treated using a cervical sym-
          pathetic blockade (CSB)/ketamine infusion (KI) combination,   Methods
          termed the SOF method. In a prior case report, the patient was
          followed for 1 year. This report followed the same patient for a   Cervical Sympathetic Block
          total of 720 days and found prolonged and sustained benefits   Detailed informed consent was obtained prior to all proce-
          with respect to PTSD and bTBI symptoms with further appli-  dures for CSB. The patient first received a right-sided CSB
          cation of the SOF method.                          with the following protocol. The patient was placed in the
                                                             supine position with the head rotated slightly to the left, with
          Keywords: SOF; PTSD; ketamine infusion; cervical sympathetic   monitoring per clinic  protocol.  The  skin  of  the neck  was
          blockade; bTBI; TBI                                cleaned  with  chlorhexidine-isopropyl  alcohol  preparation
                                                             and 2g of sterile ultrasound gel was applied. The neck was
                                                             scanned using a broadband linear transducer (8–13 MHz
                                                             from the level of the 6th to the 4th cervical vertebrae in trans-
          Introduction
                                                             verse view) using Mindray MX7. The skin at the injection
          Special Operations Forces (SOF) represent the most elite mem-  site on the lateral neck was anesthetized with 1.5mL of 1%
          bers in the U.S. Military. SOF personnel are known to develop   lidocaine. Using an in-plane approach under real-time ultra-
          higher incidences of blast traumatic brain injury (bTBI) and   sound guidance, a 22-gauge echogenic needle was placed just
          posttraumatic stress disorder (PTSD), likely due to train-  dorsal to the ventral fascia of the longus coli, medial to the
          ing and/or the intensity of  combat. They  develop comorbid   longus capitus. After aspiration, negative for CSF or blood,
          neuropsychological disorders, including anxiety, depression,   0.5mL of 0.5% bupivacaine was injected, while monitoring
          cognitive impairment, and suicidality.  Current treatments   the patient. After observing the patient for 30 seconds, a sec-
                                        1–5
          demonstrate limited efficacy in addressing the unique neuro-  ond 4-mL aliquot was injected. The patient was monitored
          psychiatric symptoms in SOF members and veterans.  Firstline   for an additional 30 seconds. After the patient verbally con-
                                                   6
          PTSD treatments have focused on psychotherapy or medica-  firmed absence of any concerning symptoms, an additional
          tion, with drop-out rates of 30%–40% in randomized clinical   4mL of 0.5% bupivacaine was slowly injected over 1 minute
          trials (RCTs). In those who have completed treatment, 60%–  for a total injection volume of 8mL for a single-level block.
          80% have recovered, with intention-to-treat analyses  report-  This was repeated at the 4th cervical level, with a total of 4mL
                                                   7
          ing recovery rates as low as a 40%.                of bupivacaine. Left-sided CSB was performed the following
                                                             day due to safety considerations following the same injection
          bTBI and PTSD present with many overlapping neuropsychi-  protocol as above.
          atric symptoms, including anxiety, irritability, insomnia, per-
          sonality changes, and memory problems, which complicates   Ketamine Infusion
          diagnostic differentiation. The patient received 5 KI and SGB   Detailed informed consent was obtained prior to all infusions
          to the left and right sides over a 5-day period (Table 1). Ac-  following a consultation. The initial infusion of racemic ket-
          cordingly, SOF personnel would benefit from simultaneous   amine hydrochloride (0.5mg/kg) was administered over 45
          treatment  for  PTSD  and  TBI.  Ketamine  infusion  (KI)  com-  minutes. Premedication with ondansetron (4-mg intravenous
          bined with cervical sympathetic block (CSB), the SOF method,   push) was used for all sessions, and an anesthesiologist was
          *Correspondence to Eugene Lipov, Stella Center, 1 Oak Hill Dr, Unit 100, Westmont, IL 60559 or hope4ptsi@gmail.com
                                                              2
                                                                           3
          1 Dr. Eugene Lipov is Chief Medical Officer at Stella Center, Westmont, IL.  Zubin Sethi and  Lt Hunter Rolain are affiliated with Midwestern
          University Chicago College of Osteopathic Medicine, Downers Grove, IL.
                                                          102
   99   100   101   102   103   104   105   106   107   108   109